NCT05116891 2023-07-03A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid TumorsCantargia ABPhase 1/2 Completed40 enrolled
NCT01773785 2021-10-13Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary CancerSpectrum Pharmaceuticals, IncPhase 2 Terminated30 enrolled